These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22633711)

  • 1. Complete atrioventricular block due to overdose of pregabalin.
    Aksakal E; Bakirci EM; Emet M; Uzkeser M
    Am J Emerg Med; 2012 Nov; 30(9):2101.e1-4. PubMed ID: 22633711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trazodone and omeprazole interaction causing frequent second-degree Mobitz type 1 atrioventricular (AV) block (Wenckebach phenomenon) and syncope: a case report and literature review.
    Akinseye OA; Alfishawy M; Radparvar F; Bakshi S
    Am J Case Rep; 2015 May; 16():319-21. PubMed ID: 26017199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregabalin: a new neuromodulator with broad therapeutic indications.
    Shneker BF; McAuley JW
    Ann Pharmacother; 2005 Dec; 39(12):2029-37. PubMed ID: 16288079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incomplete atrioventricular block in a patient on pregabalin therapy].
    Scarano V; Casillo R; Bertogliatti S; Orlando V; Terracciano AM
    Recenti Prog Med; 2013 Nov; 104(11):574-6. PubMed ID: 24336619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of pregabalin toxicity by hemodialysis in a patient with kidney failure.
    Yoo L; Matalon D; Hoffman RS; Goldfarb DS
    Am J Kidney Dis; 2009 Dec; 54(6):1127-30. PubMed ID: 19493601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible heart failure exacerbation associated with pregabalin: case discussion and literature review.
    Page RL; Cantu M; Lindenfeld J; Hergott LJ; Lowes BD
    J Cardiovasc Med (Hagerstown); 2008 Sep; 9(9):922-5. PubMed ID: 18695430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete atrioventricular block associated with rivastigmine therapy.
    Kayrak M; Yazici M; Ayhan SS; Koc F; Ulgen MS
    Am J Health Syst Pharm; 2008 Jun; 65(11):1051-3. PubMed ID: 18499878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complete atrioventricular block in a patient with rheumatoid arthritis].
    Ozgül M; Hoşcan Y; Arslan C; Karabacak M
    Turk Kardiyol Dern Ars; 2008 Jun; 36(4):263-5. PubMed ID: 18765972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible heart failure associated with pregabalin use: case report.
    Erdoğan G; Ceyhan D; Güleç S
    Agri; 2011 Apr; 23(2):80-3. PubMed ID: 21644108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pregabalin in the treatment of neuropathic pain].
    Biegstraaten M; van Schaik IN
    Ned Tijdschr Geneeskd; 2007 Jul; 151(28):1561-5. PubMed ID: 17715763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pregabalin. A new treatment for neuropathic pain].
    López-Trigo J; Sancho Rieger J
    Neurologia; 2006 Mar; 21(2):96-103. PubMed ID: 16525916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of pregabalin on pain-related sleep interference in diabetic peripheral neuropathy or postherpetic neuralgia: a review of nine clinical trials.
    Roth T; van Seventer R; Murphy TK
    Curr Med Res Opin; 2010 Oct; 26(10):2411-9. PubMed ID: 20812792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial.
    Richter RW; Portenoy R; Sharma U; Lamoreaux L; Bockbrader H; Knapp LE
    J Pain; 2005 Apr; 6(4):253-60. PubMed ID: 15820913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregabalin in the treatment of Charles Bonnet syndrome.
    Sawant NS; Bokdawala RA
    J Pak Med Assoc; 2013 Apr; 63(4):530-1. PubMed ID: 23905458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
    Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.
    Tarride JE; Gordon A; Vera-Llonch M; Dukes E; Rousseau C
    Clin Ther; 2006 Nov; 28(11):1922-34. PubMed ID: 17213013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time to onset of neuropathic pain reduction: A retrospective analysis of data from nine controlled trials of pregabalin for painful diabetic peripheral neuropathy and postherpetic neuralgia.
    Sharma U; Griesing T; Emir B; Young JP
    Am J Ther; 2010; 17(6):577-85. PubMed ID: 20393345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregabalin: its pharmacology and use in pain management.
    Gajraj NM
    Anesth Analg; 2007 Dec; 105(6):1805-15. PubMed ID: 18042886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: current evidence and future directions.
    Gilron I
    Curr Opin Anaesthesiol; 2007 Oct; 20(5):456-72. PubMed ID: 17873599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.
    Zin CS; Nissen LM; O'Callaghan JP; Duffull SB; Smith MT; Moore BJ
    J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.